ENTA – Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals, Inc.ENTA
$7.11Name : Enanta Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $151,987,632.00
EPSttm : -4.53
Enanta Pharmaceuticals, Inc.
$7.11
6.20%$0.47Float Short %
12.4
Margin Of Safety %
Put/Call OI Ratio
0.15
EPS Next Q Diff
-0.15
EPS Last/This Y
1.26
EPS This/Next Y
0.7
Price
7.11
Target Price
18.2
Analyst Recom
1.6
Performance Q
17.52
Relative Volume
1.19
Beta
0.88
Ticker: ENTA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | ENTA | 7.89 | 0.10 | 0.00 | 1227 |
| 2025-07-07 | ENTA | 7.64 | 0.10 | 105.00 | 1224 |
| 2025-07-08 | ENTA | 7.75 | 0.19 | 0.00 | 1329 |
| 2025-07-09 | ENTA | 7.14 | 0.19 | 1.30 | 1324 |
| 2025-07-10 | ENTA | 6.95 | 0.30 | 0.00 | 1445 |
| 2025-07-11 | ENTA | 6.56 | 0.30 | 0.00 | 1445 |
| 2025-07-14 | ENTA | 6.95 | 0.31 | 0.20 | 1390 |
| 2025-07-15 | ENTA | 6.58 | 0.30 | 999.99 | 1450 |
| 2025-07-16 | ENTA | 7.08 | 0.30 | 0.33 | 1452 |
| 2025-07-17 | ENTA | 7.24 | 0.30 | 0.00 | 1454 |
| 2025-07-18 | ENTA | 7.55 | 0.30 | 0.00 | 1453 |
| 2025-07-21 | ENTA | 7.76 | 0.12 | 0.00 | 694 |
| 2025-07-22 | ENTA | 7.69 | 0.12 | 0.00 | 728 |
| 2025-07-23 | ENTA | 7.72 | 0.12 | 0.00 | 727 |
| 2025-07-24 | ENTA | 7.34 | 0.12 | 0.10 | 737 |
| 2025-07-25 | ENTA | 7.41 | 0.12 | 0.10 | 737 |
| 2025-07-28 | ENTA | 8.01 | 0.12 | 0.00 | 759 |
| 2025-07-29 | ENTA | 8.08 | 0.11 | 0.00 | 783 |
| 2025-07-30 | ENTA | 7.6 | 0.09 | 999.99 | 941 |
| 2025-07-31 | ENTA | 7.57 | 0.15 | 999.99 | 1011 |
| 2025-08-01 | ENTA | 7.11 | 0.15 | 0.05 | 1013 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | ENTA | 7.89 | 24.3 | - | -3.89 |
| 2025-07-07 | ENTA | 7.65 | 24.3 | - | -3.89 |
| 2025-07-08 | ENTA | 7.75 | 24.3 | - | -3.89 |
| 2025-07-09 | ENTA | 7.13 | 24.3 | - | -3.89 |
| 2025-07-10 | ENTA | 6.98 | 24.3 | - | -3.89 |
| 2025-07-11 | ENTA | 6.56 | 24.3 | - | -3.89 |
| 2025-07-14 | ENTA | 6.96 | 24.3 | - | -3.89 |
| 2025-07-15 | ENTA | 6.59 | 24.3 | - | -3.89 |
| 2025-07-16 | ENTA | 7.09 | 24.3 | - | -3.89 |
| 2025-07-17 | ENTA | 7.23 | 24.3 | - | -3.89 |
| 2025-07-18 | ENTA | 7.53 | 24.3 | - | -3.89 |
| 2025-07-21 | ENTA | 7.78 | 24.3 | - | -3.89 |
| 2025-07-22 | ENTA | 7.67 | 24.3 | - | -3.89 |
| 2025-07-23 | ENTA | 7.73 | 24.3 | - | -3.89 |
| 2025-07-24 | ENTA | 7.34 | 24.3 | - | -3.89 |
| 2025-07-25 | ENTA | 7.40 | 24.3 | - | -3.89 |
| 2025-07-28 | ENTA | 8.00 | 24.3 | - | -3.89 |
| 2025-07-29 | ENTA | 8.10 | 24.3 | - | -3.89 |
| 2025-07-30 | ENTA | 7.61 | 24.3 | - | -3.89 |
| 2025-07-31 | ENTA | 7.58 | 24.3 | - | -3.89 |
| 2025-08-01 | ENTA | 7.11 | 17.3 | - | -4.22 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | ENTA | 3.06 | -8.63 | 12.58 |
| 2025-07-07 | ENTA | 3.06 | -8.65 | 12.58 |
| 2025-07-08 | ENTA | 3.06 | -8.65 | 12.58 |
| 2025-07-09 | ENTA | 3.06 | -8.65 | 12.58 |
| 2025-07-10 | ENTA | 3.06 | -8.65 | 12.58 |
| 2025-07-11 | ENTA | 3.06 | -8.65 | 12.20 |
| 2025-07-14 | ENTA | 3.06 | -8.56 | 12.20 |
| 2025-07-15 | ENTA | 3.06 | -8.56 | 12.20 |
| 2025-07-16 | ENTA | 3.06 | -8.56 | 12.20 |
| 2025-07-17 | ENTA | 3.06 | -8.56 | 12.20 |
| 2025-07-18 | ENTA | 3.06 | -8.56 | 12.20 |
| 2025-07-21 | ENTA | 3.06 | -8.11 | 12.20 |
| 2025-07-22 | ENTA | 3.06 | -8.11 | 12.20 |
| 2025-07-23 | ENTA | 3.06 | -8.11 | 12.20 |
| 2025-07-24 | ENTA | 3.06 | -8.11 | 12.20 |
| 2025-07-25 | ENTA | 3.06 | -8.11 | 12.40 |
| 2025-07-28 | ENTA | 3.06 | -8.76 | 12.40 |
| 2025-07-29 | ENTA | 3.06 | -8.76 | 12.40 |
| 2025-07-30 | ENTA | 3.06 | -8.76 | 12.40 |
| 2025-07-31 | ENTA | 3.06 | -8.76 | 12.40 |
| 2025-08-01 | ENTA | 3.06 | -8.76 | 12.40 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.06
Avg. EPS Est. Current Quarter
-0.81
Avg. EPS Est. Next Quarter
-1.21
Insider Transactions
3.06
Institutional Transactions
-8.76
Beta
0.88
Average Sales Estimate Current Quarter
16
Average Sales Estimate Next Quarter
15
Fair Value
Quality Score
21
Growth Score
29
Sentiment Score
84
Actual DrawDown %
93
Max Drawdown 5-Year %
-95.6
Target Price
18.2
P/E
Forward P/E
PEG
P/S
2.36
P/B
1.62
P/Free Cash Flow
EPS
-4.54
Average EPS Est. Cur. Y
-4.22
EPS Next Y. (Est.)
-3.52
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-149.57
Relative Volume
1.19
Return on Equity vs Sector %
-126.8
Return on Equity vs Industry %
-108.2
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.33
EBIT Estimation
Enanta Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 131
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
stock quote shares ENTA – Enanta Pharmaceuticals Inc Stock Price stock today
news today ENTA – Enanta Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ENTA – Enanta Pharmaceuticals Inc yahoo finance google finance
stock history ENTA – Enanta Pharmaceuticals Inc invest stock market
stock prices ENTA premarket after hours
ticker ENTA fair value insiders trading